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Abstract 
Background: There is growing interest in the potential of artificial intelligence (AI) to support decision 
making in health and social care settings. There is, however currently limited evidence of the 
effectiveness of these systems. 
Aims: To investigate the effectiveness of AI-based computerised decision support (CDS) systems in 
health and social care settings.  
Methods: We conducted a systematic literature review to identify relevant randomised controlled 
trials (RCTs) conducted between 2013 and 2018. We searched the following databases: MEDLINE, 
EMBASE, CINAHL, Psychinfo, Web of Science, Cochrane Library, ASSIA, Emerald, Health Business 
Fulltext Elite, ProQuest Public Health, Social Care Online, and grey literature sources. Search terms 
were conceptualised into three groups: AI-related terms, CDS-related terms, and terms relating to 
health and social care. Terms within groups were combined using the Boolean operator OR, and 
groups were combined using the Boolean operator AND. Two reviewers independently screened 
studies against the eligibility criteria and then extracted data on eligible studies were extracted by two 
independent reviewers onto a customised sheet. The quality of studies was assessed through the 
Critical Appraisal Skills Programme (CASP) Checklist for RCTs. We then conducted an interpretive 
synthesis. 
Findings: We identified 68 hits of which five studies satisfied the inclusion criteria. These studies varied 
substantially in relation to quality, settings, outcomes and technologies. None of the studies were 
conducted in social care settings and three RCTs showed no difference in patient outcomes. Of these, 
one investigated the use of Bayesian triage algorithms on forced expiratory volume in 1 second (FEV1) 
and health-related quality of life in lung transplant patients, one investigated the effect of image 
pattern recognition on neonatal development outcomes in pregnant women, and another 
investigated the effect of the Kalman filter technique for warfarin dosing suggestions on time in 
therapeutic range. 
The remaining two RCTs, investigating computer vision and neural networks on medication adherence 
and the impact of learning algorithms on assessment time of patients with gestational diabetes, 
showed statistically significant and clinically important differences to the control groups receiving 
standard care. However, these studies tended to be of low quality lacking detailed descriptions of 
methods and only one study used a double-blind design.  
Conclusions and implications: The evidence of effectiveness of AI to support decision making in health 
and social care settings is limited. Two of the trials demonstrated substantial potential health gains, 
but there were concerns in relation to the quality of these studies. It is unlikely that any single overall 
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message surrounding effectiveness will emerge – rather effectiveness of interventions is likely to be 
context specific. 
Background 
There is now an increasing focus on health information technology (HIT) to improve the quality, safety 
and efficiency of care, to tackle demographic shifts, variations in the quality of care, and ongoing 
concerns around safety, and cope with increasing economic pressures.(1) There is a growing empirical 
evidence base that knowledge-based computerised decision support (CDS), and in particular 
knowledge-based Clinical Decision Support Systems which form a subcategory of these, have the 
potential to improve practitioner performance.(2,3) Such technologies commonly draw on an existing 
knowledge base of existing research evidence and/or guidelines to provide logical reasoning-based 
expert advice. Knowledge-based CDS is different from data-driven CDS in that it does not involve the 
creation of new knowledge.  
Recent reviews have shown that artificial intelligence (AI) algorithms in digital health interventions 
can be effective in improving health outcomes across a range of conditions but none has focused on 
data-driven CDS systems.(4,5) These systems are designed to emulate human performance typically 
by analysing large complex datasets. There are now over 16 AI-based products approved by the United 
States (US) Food and Drug Administration (FDA).1 
There is growing interest from the public, health service providers, policymakers, system vendors, the 
media and funding bodies, in the potential of CDS linked to data-driven AI-based algorithms as these 
can help to quantify risk and facilitate human decision making. However, there has to date been no 
systematic attempt to scope the empirical evidence base in relation to the effectiveness of CDS 
systems linked to data-driven AI-based algorithms and some have cautioned against the hype 
associated with AI-based technologies used in healthcare delivery.(6,7) 
We aimed to investigate the effectiveness of data-driven AI to support decision making in health and 
social care settings.  
Methods 
Design 
We undertook a systematic review of published empirical research. The systematic review protocol is 
registered with the PROSPERO International Prospective Register of Systematic Reviews and reported 
                                                          
1 https://medium.com/syncedreview/ai-powered-fda-approved-medical-health-projects-a19aba7c681 
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using the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) 
guidelines.(8,9)  
We used the PICO framework to form the research questions and to focus the literature search (see 
Table 1). 
Table 1: PICO framework for the review 
P (Population) Health and social care users (patients and citizens), health and social care 
professionals and managers 
I (Intervention) AI-based CDS systems 
C (Comparator(s)) Non-AI-based approaches 
O (Outcomes) Practitioner performance 
Patient, citizen and population outcomes 
Health system outcomes 
 
Search strategy 
We searched the published empirical literature from 2013 until September 2018 for work investigating 
AI to support decision making in health and social care settings. The start date was chosen as in 2013 
IBM’s Watson was first used in the medical field demonstrating the potential usefulness of AI 
algorithms in healthcare.(10)  
We searched the following databases: MEDLINE, EMBASE, CINAHL, Psychinfo, Web of Science, 
Cochrane Library, ASSIA, Emerald, Health Business Fulltext Elite, ProQuest Public Health, Social Care 
Online, and grey literature sources. Search terms were divided into three groups: AI-related terms, 
CDS-related terms, and terms relating to health and social care settings. Terms within groups were 
combined using the Boolean operator OR, and groups were combined using the Boolean operator 
AND. We applied methodological filters to find randomised controlled trials (RCTs). Search strategies 
for each database can be viewed in Appendix 1. 
Eligibility criteria 
Studies were eligible for inclusion if they were conducted in health and social care settings and 
published in English; if they focused on AI; and if they used technological systems for clinical, 
managerial and self-management decision making.  
Studies were excluded if they were not RCTs or if they fell outside our scope of interest. This included, 
for example, studies that evaluated technology that is not commonly associated with systems that are 
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driven by the analysis of patterns and models emerging from very large datasets, and those that did 
not focus on a combination of CDS and AI. 
 
Study selection 
Titles and abstracts of studies identified from the searches were screened by two investigators (MC 
and SK for abstracts, MC and ZS for full texts), who screened all retrieved potentially eligible studies 
independently against the above criteria. Any disagreements were resolved by discussion or, if 
necessary, through arbitration by KC. 
Quality assessment and analysis 
Formal quality assessment of eligible studies was undertaken independently by two reviewers (MC 
and ZS) using the Critical Appraisal Skills Programme (CASP) Checklist for RCTs.(11) Disagreements 
were resolved through discussion  or, if necessary, through arbitration by KC. 
Data extraction  
Data were abstracted onto a customised data extraction sheet in Microsoft Excel by MC and ZS. Data 
were extracted on: authors, title, journal, year, country, healthcare setting, participant number and 
type, age, timescale, type of AI, type of decision support, comparator (non-AI/CDS based approaches), 
health problem/condition, outcomes assessed, impact on practitioner performance, impact on patient 
outcomes, impact on patient self-management, other estimates of effectiveness, enablers and 
barriers, reviewer notes, and reviewer interpretation. 
Data analysis 
A quantitative synthesis was judged to be inappropriate due to the heterogeneity of technologies 
being assessed and care contexts. Data were therefore descriptively summarised and narratively 
synthesised. We followed the following steps in conducting an interpretive synthesis of our findings: 
(1) describing the various functions of technological systems; (2) noting the context of the various 
studies and settings; (3) summarising evidence of effectiveness; and (4) summarising study quality. 
Results 
We identified 69 potentially eligible studies. After removing duplicates, we screened 68 abstracts. At 
screening stage, 31 abstracts were dropped. Most excluded abstracts (n=16) did not include AI. Study 
protocols (n=10) and non-randomized studies (n=10) were also excluded.  We assessed 37 full-text 
articles for eligibility, from which 32 were excluded. Ineligible articles did not combine AI and CDS 
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functionality (n=15), did not have AI as their primary focus (n=7), did not have RCT designs (n=6), did 
not report our outcomes of interest (n=2), or did not have interventions that were data-driven (n=2) 
were excluded.  
Five papers were included in final review (Figure 1). Of these, two were conducted in the US, one in 
Spain, one in Denmark, and one in the United Kingdom. Two included RCTs were conducted in 
inpatient settings, two in a home care setting, and one in an outpatient setting. Key characteristics of 
included studies are summarised in Table 2. 
Figure 1: PRISMA folow diagram for screened and included studies 
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Table 2: Characteristics of included studies 
Author Title Source 
(Journa
l) 
Ye
ar 
Coun
try 
of 
setti
ng 
Healt
hcare 
settin
g 
Particip
ant 
Number 
and 
type 
Age Time 
Scale 
Type of 
AI if 
include 
Type of 
decision 
support if 
included 
Compa
rator 
(non 
AI / 
CDS 
based 
approa
ches) 
Health 
proble
m / 
conditi
on 
Outco
mes 
assesse
d 
Impact 
on 
practiti
oner 
perfor
mance 
Was 
the AI 
CDS 
approac
h more 
successf
ul 
Impact 
on 
patient 
outcom
es 
Any 
impact 
on 
patient 
self-
manage
ment?  
Other 
estimat
es of 
effectiv
eness 
Oth
er 
ena
bles 
and 
barr
iers 
Caballero
-Ruiz E, 
Garcia-
Saez G, 
Rigla M, 
Villaplana 
M, Pons 
B, 
Hernando 
ME.  
A web-
based 
clinical 
decision 
support 
system 
for 
gestatio
nal 
diabetes
: 
Automat
ic diet 
prescript
ion and 
detectio
n of 
insulin 
needs. 
Interna
tional 
Journal 
of 
Medica
l 
Inform
atics 
20
17 
Spai
n 
Remo
te - 
home 
450 
Pregnan
t women 
Not 
state
d 
17 
mont
hs 
CDS to 
manage 
treatme
nt of 
patient
s with 
gestatio
nal 
diabete
s 
through 
teleme
dicine 
whether 
patient 
needed 
insulin 
therapy / 
or patient 
demonstr
ate good 
metabolic 
control 
Standa
rd care 
Gestati
onal 
diabete
s 
manag
ed 
remote
ly 
throug
h 
teleme
dicine 
and 
patient 
upload
ed data 
Access 
to 
speciali
sed 
healthc
are 
assistan
ce, 
reduce 
the 
evaluati
on time 
for 
patient
s, and 
avoid 
gestatio
nal 
diabete
s 
adverse 
outcom
es. 
Clinical 
time 
require
d per 
patient 
number 
of face 
to face 
visits 
frequen
Assess
ment 
time 
decrea
sed by 
almost 
a third. 
Face to 
face 
reduce
d by 
88% 
but 
overall 
time 
the 
same, 
autom
atic 
detecti
on of 
100% 
who 
needed 
insulin 
therap
y and 
diet 
adjust
ment 
Yes High 
patient 
satisfac
tion 
(but 
wasn't 
compar
ed to a 
control 
so 
basicall
y saying 
that it 
is 
accepta
ble to 
patient
s) 
Not 
explicitl
y stated 
but if 
saves 
clinical 
time, 
saves 
patient 
time 
and 
travel 
from 
fewer 
visits 
and 
effectiv
ely is a 
significa
nt 
increase 
in self-
manage
ment 
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cy and 
duratio
n of 
telemat
ic 
reviews 
patient 
complia
nce to 
self-
monito
ring 
patient 
satisfac
tion 
Finkelstei
n SM, 
Lindgren 
BR, 
Robiner 
W, 
Lindquist 
R, Hertz 
M, Carlin 
BP, et al.  
A 
randomi
zed 
controlle
d trial 
compari
ng 
health 
and 
quality 
of life of 
lung 
transpla
nt 
recipient
s 
followin
g nurse 
and 
compute
r-based 
triage 
utilizing 
home 
spiromet
ry 
monitori
ng. 
Telemed
icine 
journal 
Journal 
of the 
Americ
an 
Teleme
dicine 
Associa
tion 
20
13 
USA Inpati
ent 
65 lung 
transpla
nt 
recipient
s 
37-
69 
Octob
er 
2006-
April 
2009 
plus 
one 
year 
follow 
up 
  Compute
r based 
Bayesian 
algorithm 
Manua
l nurse 
decisio
n 
Lung 
transpl
ant 
Effectiv
eness 
of 
triaging 
clinical 
interve
ntions 
in lung 
transpl
ant 
recipien
ts 
particip
ating in 
home 
monito
ring 
No 
differe
nces in 
outco
mes 
measur
ed. 
Change
s from 
baselin
e after 
year of 
forced 
expirat
ory 
volume
, SF36, 
QOL 
No None No     
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and e-
health 
Infant 
Collabora
tive 
Group.  
Comput
erised 
interpret
ation of 
fetal 
heart 
rate 
during 
labour 
(INFANT)
: a 
randomi
sed 
controlle
d trial. 
(10080):
1719-
29.  
Lancet. 
2017;3
89 
North 
Americ
an 
Edition 
20
17 
UK 
and 
Irela
nd 
Labou
r 
Ward 
women 
in labour  
35+ 
weeks 
gestatio
n having 
continuo
us 
electroni
c fetal 
monitori
ng and 
number 
16 
or 
olde
r 
Jan 
2010-
Augus
t 
2013 
Decisio
n 
support 
softwar
e 
Interpret
ation of 
cardiotoc
ographs 
'INFANT' 
Usual 
care / 
no 
softwa
re 
decisio
n 
suppor
t 
Wome
n in 
labour 
with 
continu
ous 
electro
nic 
fetal 
monito
ring 
  NA No 
differen
ce 
No 
differen
ce in 
any 
neonat
al 
outcom
e of 
develop
ment 
assess
ment at 
age 2 
NA NA NA 
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Labovitz 
DL, 
Shafner L, 
Reyes Gil 
M, 
Virmani 
D, Hanina 
A. ; a 
journal of 
cerebral 
circulatio
n. 
2017;48(
5):1416-
9.  
Using 
Artificial 
Intellige
nce to 
Reduce 
the Risk 
of 
Nonadh
erence 
in 
Patients 
on 
Anticoag
ulation 
Therapy 
Stroke 20
17 
USA Outpa
tient 
care 
28 
adults 
with 
recently 
diagnos
ed 
ischemic 
stroke 
receivin
g any 
anticoag
ulation 
"Adu
lts" 
but 
age 
not 
speci
fied 
12 
week 
Comput
er 
vision & 
neural 
networ
ks 
Measurin
g & 
increasin
g 
medicatio
n 
adherenc
e 
No 
daily 
monito
ring 
Ischemi
c 
stroke 
& 
medica
tion 
adhere
nce 
No 
primary 
outcom
e 
specifie
d. 
Outcom
es were 
mean 
cumula
tive 
adhere
nce 
based 
on the 
AI 
platfor
m and 
adhere
nce 
based 
on 
plasma 
concent
ration 
levels 
and pill 
count. 
Subgro
up 
analysis 
was 
also 
conduct
ed and 
the 
same 
outcom
es were 
reporte
d for 
patient
s who 
receive
d 
DOACs. 
  Yes Mean 
cumula
tive 
adhere
nce 
based 
on the 
AI 
platfor
m was 
90.5%. 
Mean 
cumula
tive 
adhere
nce 
indicate
d by 
plasma 
drug 
concent
ration 
was 
100% 
for the 
interve
ntion 
and 
50% for 
the 
control 
group. 
Mean 
cumula
tive 
adhere
nce 
indicate
d by pill 
count 
was 
97.2% 
for the 
interve
ntion 
and 
Require
s 
patients 
to use 
the 
applicat
ion to 
visually 
confirm 
medicat
ion 
ingestio
n 
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90.6% 
for the 
control 
group. 
For 
patient
s 
reccein
g 
DOACs, 
mean 
cumula
tive 
adhere
nce 
based 
on the 
AI 
platfor
m was 
90.1%, 
mean 
cumula
tive 
adhere
nce 
indicate
d by pill 
count 
was 
96.4% 
for the 
interve
ntion 
and 
90.9% 
for the 
control 
group 
and 
mean 
cumula
tive 
adhere
nce 
indicate
12 
 
d by 
plasma 
drug 
concent
ration 
was 
100% 
for the 
interve
ntion 
and 
33% for 
the 
control. 
Nielsen 
PB, 
Lundbye-
Christens
en S, van 
der Male 
M, Larsen 
TB.
 
 
  
Using a 
personal
ized 
decision 
support 
algorith
m for 
dosing in 
warfarin 
treatme
nt: A 
randomi
sed 
controlle
d trial 
Clinical 
Trials 
and 
Regulat
ory 
Science 
in 
Cardiol
ogy 
20
17 
Den
mark
  
Home 
health 
settin
g 
191 
participa
nts 
Mea
n 
age 
of 65 
year
s 
Patien
ts 
enroll
ed 
from 
Septe
mber 
2014 
to 
Nove
mber 
2014 
and 
then 
follow
ed up 
for at 
least 
90 
days 
with a 
mean 
follow 
up of 
140 
days 
Comput
erized 
dosing 
algorith
ms for 
warfari
n. If a 
particip
ant was 
allocate
d to 
interve
ntion, 
he/she 
would 
receive 
an 
algorith
m-
calculat
ed 
dosage 
suggesti
on. 
Personali
sed 
support 
for 
warfarin 
dosing 
(Kalman 
filter 
technique
) 
No AI 
algorit
hm 
based 
suppor
t - in 
contra
st, the 
dosage 
sugges
tion in 
the 
placeb
o-arm 
would 
equal 
last 
week's 
dose 
of 
warfari
n. 
Eligible 
particip
ants 
were 
patient
s with 
an 
indicati
on for 
warfari
n 
treatm
ent 
who 
were in 
steady 
state 
patient 
self 
manag
ement 
(PSM) 
treatm
ent 
No 
interfac
e with 
practiti
oners - 
this 
group 
were 
on 
patient 
self 
manage
ment 
(PSM) 
treatm
ent 
The 
interve
ntion 
arm 
achiev
ed a 
TTR of 
81.6, 
while 
the 
placeb
o arm 
attaine
d a TTR 
of 80.9 
(differe
nce 
[interv
ention 
arm 
minus 
placeb
o arm]: 
0.67 
(95% 
confide
nce 
interval 
−2.93 
to 
4.27) 
The 
number 
of ‘non-
complia
nt’ 
registra
tions 
(disagre
ement 
with 
dosage 
suggesti
on) was 
differen
t in the 
two 
trial 
arms, 
average 
15% per 
particip
ant in 
the 
interve
ntion 
arm and 
6% in 
the 
placebo 
arm. 
Unable 
"A 
second
ary 
study 
measur
e was 
the log-
transfor
med 
INR 
variabili
ty. This 
method 
attemp
ts to 
describ
e the 
degree 
to 
which 
each 
individu
al's INR 
value 
varies 
relative 
to 
his/her
s 
previou
s INR 
Cannot 
identify 
any 
No 
differe
nce 
betwee
n the 
two 
trial-
arms in 
a high-
quality 
warfari
n 
treatm
ent 
setup. 
Howev
er in 
general
, the 
model 
perfor
med 
similarl
y as to 
routine 
patient 
self-
manag
ement 
care. 
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to find 
clear 
pattern 
or 
reason 
for this 
value. 
The 
differen
ce in 
INR 
variabili
ty was 
0.30 
(0.14 to 
0.47), 
favouri
ng the 
placebo 
arm in 
terms 
of 
lower 
log 
transfor
med 
variabili
ty" 
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Variation in study size, technological systems, timescales 
We observed substantial variations in the size of studies (from 28 to 47062 participants), technological 
systems (i.e. type of AI-based CDS) and timescales over which the systems were assessed.(12-16) All 
included studies focused on specific patient populations (often with long-term conditions), namely: 
women with gestational diabetes,(12) women in labour,(14), adults with ischemic stroke,(15) 
thrombosis patients,(16) and lung transplant recipients.(13)  
Types of AI facilitated decision support also varied widely. One study assessed learning algorithms to 
support patient self-management;(12) another study assessed algorithms facilitating automated 
triaging based on existing datasets;(13) and another study assessed algorithms facilitating the 
interpretation of fetal cardiotocographs (CTGs) through image pattern recognition.(14) The final two 
studies assessed the use of neural networks to facilitate medication adherence,(15) and the Kalman 
filter technique (an algorithm using temporal measurements) to personalise warfarin dosing 
recommendations for patient self-management.(16) 
Three studies investigated decision making in patients,(12,15,16) whereas the others focused on 
decision making in healthcare professionals.(13,14) 
We further found large variations in timescales of studies from 12 weeks to 3.5 years in 
duration.(14,15) 
Patient outcomes needed 
In terms of outcomes, studies most frequently assessed impact of the intervention on patient 
outcomes, but these varied significantly across RCTs due to the differences in study populations. For 
example, Finkelstein and colleagues assessed forced expiratory volume in 1 second (FEV1) and health-
related quality of life in lung transplant patients,(13) whilst others assessed neonatal development 
outcomes,(14) medication adherence,(15) and time in therapeutic warfarin range.(16) Two studies 
also assessed impacts on practitioner performance. These were RCTs examining the effectiveness of 
triaging interventions in lung transplant recipients,(13) and the impact on the clinician assessment 
time of patients.(12)  
Caballero-Ruiz and colleagues applied a learning algorithm to a CDS to manage treatment of patients 
with gestational diabetes through telemedicine and compared this to standard care.(12) They 
assessed access to specialised healthcare, evaluation time for patients, adverse gestational diabetes 
outcomes, clinical time required per patient, number of face-to-face visits, frequency and duration of 
telematic reviews, patient compliance, and patient satisfaction. 
15 
 
Finkelstein et al investigated the effectiveness of a Bayesian triage algorithm for automated triaging 
based on analysing data from a home monitoring program in lung transplant patients, and assessed 
the effectiveness of triaging clinical interventions compared with manual nurse decision.(13)  
The INFANT Collaborative Group tested the effectiveness of image pattern recognition in the 
interpretation of CTGs of women in labour and assessed neonatal outcomes of development at age 2 
compared to usual care.(14)   
A study conducted by Labovitz and colleagues assessed the effectiveness of computer vision and 
neural networks in improving medication adherence in patients with ischemic stroke and compared it 
with no daily monitoring.(15)  
The final study conducted by Nielsen and colleagues assessed the effectiveness of an algorithm on 
warfarin dosing recommendations to patients to prevent thromboembolic events.(16) The control 
arm included no AI algorithm-based support, with the dosage suggestion equalling the previous 
week's dose of warfarin. 
Quality assessment 
The quality of studies was extremely variable. Details of methods were in some instances difficult to 
find and only one study used a double-blind design.(13) In another study, only patients were 
blinded,(16) another one used no blinding,(14) and for the remaining two it was unclear whether 
blinding took place.(12,15) We provide a risk of bias table below (Table 3).  
Table 3: Risk of bias table of included studies 
Study Random 
sequence 
generation 
Allocation 
concealment 
Blinding of 
participants 
and 
personnel 
Blinding of 
outcome 
assessment 
Incomplete 
outcome 
data 
Selective 
reporting 
Other 
bias 
Caballero-
Ruiz et al 
2017  
Low risk Low risk Unclear Unclear High risk High risk High 
risk 
Finkelstein et 
al 2013 
Low risk Low risk Low risk Unclear Low risk Low risk Low 
risk 
16 
 
Infant 
Collaborative 
Group 2017 
Low risk Low risk High risk Unclear Low risk Low risk Low 
risk 
Labovitz et al 
2017 
Unclear Low risk Unclear Unclear High risk Unclear High 
risk 
Nielsen et al 
2017 
Low risk Low risk Low risk Unclear Low risk Low risk Low 
risk 
 
Mixed evidence of effectiveness  
Evidence of effectiveness was mixed, with two studies showing no statistically significant difference 
to the control group,(13,14) and two showing statistically significant and clinically relevant differences 
between the intervention and the control groups.(12,15,16) Detailed study characteristics and 
outcomes are provided in Table 2.  
One study with high risk of bias, focussing on a learning algorithm to help with managing gestational 
diabetes reported positive findings. It showed a decrease in assessment time (from 15 minutes in the 
control group to 2.778 ± 0.858 minutes in the intervention group per patient), and a reduction in face-
to-face consultations (3.207 ± 2.846 visits in the control group and 0.367 ± 0.901 in the intervention 
group).(12) Another study, also with high risk of bias, using computer vision and neural networks 
reported that the mean cumulative medication adherence indicated by plasma drug concentration 
was 100% for the intervention and 33% for the control group.(15)  
Other RCTs with low risk of bias showed no difference. One trial using a Bayesian algorithm tool for 
remote monitoring, follow-up and triage of patients after lung transplants, reported no difference in 
the detection of changes in patients’ FEV1 and quality of life between intervention and control 
groups.(13) Both groups showed non-significantly different decreases over two years, including a 2% 
FEV1 decrease (p= 0.721) at year 1 and a 3% decrease at year 2 (p= 0.861). 
Another trial drawing on image pattern recognition for the computerised interpretation of CTGs 
during labour did not show an effect on neonatal outcomes.(14)  Poor neonatal outcomes were 
reported in 172 (0.7%) babies in the AI-based CDS group versus 171 (0.7%) in control group. 
A third trial showed no difference when comparing personalised algorithm generated warfarin dosing 
recommendations for thrombosis patients with standard care, showed that the intervention achieved 
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a time in therapeutic range of 81.6, while the control group achieved 80.9 (difference: 0.67 (95% 
confidence interval −2.93 to 4.27).(16)  
Discussion 
Overall, the evidence of effectiveness of AI to support decision making in health and social care 
settings is limited. We found a very small number of relevant studies with large variability in quality, 
settings, outcomes and technologies. No identified studies were conducted in social care settings and 
none included work investigating any enablers and/or barriers for the use of data-driven AI to support 
decisions. Three RCTs showed no difference, whereas two showed statistically significant and clinically 
relevant differences to the control groups. 
Strengths and limitations 
Our review is a first of type examining the use of data-driven AI to support decision making. However, 
as we have shown, the number of potentially relevant RCTs is limited, perhaps reflecting the 
immaturity of the field, but also potentially due to overlapping definitions surrounding CDS and AI. For 
example, it was at times hard for the research team to distinguish between knowledge-driven and 
data-driven applications. Moreover, the conclusions that can be drawn from this work are limited as 
all included studies compared AI-based CDS with standard care. Ideally, the comparison should be AI-
enabled CDS versus CDS to see if AI makes a difference to standard knowledge-based CDS. 
Integration of findings with the current literature 
The lack of eligible studies may call for widening the search criteria to include different methodologies 
to assess the effectiveness of data-driven AI algorithms to support decision making in health and social 
care settings.(17)  
Nevertheless, despite these perhaps inevitable challenges, we have helped to provide a starting point 
for work in this area going forward. There is a need to look at potential unintended consequences and 
challenges associated with novel systems in combination with RCTs.(18) Concurrent qualitative 
evaluation can help to address some of these issues and also help to identify contextual dynamics and 
potential reasons for effectiveness (or lack thereof).(19)  
It may be that the lack of existing RCTs in the area is due to issues with data access for AI specialists.(20) 
This may also help to explain the involvement of system developers in 50% of our included studies – 
they may have had privileged access to data in their systems. The more data algorithms can draw on, 
the more effective they become, but access to large curated datasets on which algorithms can be 
trained is currently still hard to achieve.(19,20)  
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More generally, there is a need to remember that, as in knowledge-driven CDS, the ultimate 
responsibility of the decision still lies with the human. As such, those at the receiving end of data-
driven AI based CDS need to be trained to make decisions informed by these systems. This may require 
developing new skills and/or ways of considering evidence.(21)  
Policy recommendations and implications for practice emerging from this work 
Our work may support those cautioning against the assumed effectiveness of AI and the associated 
hype surrounding these technologies.(7) Policymakers need to be aware that evidence of 
effectiveness is limited at this stage. In order to address the variability of existing work in this area, 
strategic decision makers may need to extract key areas of focus for research and innovation within 
their locales where applications have the greatest potential to meet a major service need and where 
they are most likely to deliver real impact. Ideally, these should be designed to be comparable in terms 
of technologies and disease areas, and include qualitative formative evaluation components to 
capture emerging challenges. The limited details reported in the methods sections of included studies, 
particularly in relation to AI algorithms, also calls for clearer standards of reporting of studies to ensure 
rigour and independent assessment of risk of bias. 
As the application of AI is gaining momentum, there is likely to be an increasing need for developing 
associated evaluation frameworks, reporting guidelines and understanding transferability beyond 
experimental contexts. A focus on unintended consequences, positive or negative, should be 
fundamental to these efforts.  
Conclusions 
AI-based data-driven decision making in healthcare settings may have significant potential. Two of the 
trials included in this work showed substantial gains, but there are concerns in relation to the quality 
of these studies.  
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Appendix 1 – Search strategies 
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Database search record 
Database: 
e.g. 
OVIDSP/Medline 
Saved search strategy 
name 
Search strategy (including limits and filters) 
Medline Artificial Intelligence 
Reviews 1. exp Artificial Intelligence/ 
 
2. (artificial intelligence or AI).tw.  
3. ((comput* or artificial or machine) adj3 
intelligence).tw. 
 
4. exp Machine Learning/  
5. ((machine or artificial or deep) adj3 learning).tw.  
6. exp Algorithms/  
7. algorithm*.tw.  
8. (data driven or data-driven).tw.  
9. (computer adj3 (assist* or generat*)).tw.  
10. neural network*.tw.  
11. perceptron*.tw.  
12. connectionist model.tw.  
13. exp Support Vector Machine/  
14. (support vector adj3 (machine or network*)).tw.  
15. (statistic* adj3 (map* or learn*)).tw.  
16. chatbot*.tw.  
17. Virtual private agent*.tw.  
18. virtual intelligent agent*.tw.  
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19. animated character*.tw.  
20. SIRI.tw.  
21. Recommendation system*.tw.  
22. ((image or face or facial) adj3 recogni*).tw.  
23. exp ROBOTICS/  
24. robot*.tw.  
25. (virtual adj3 assistant*).tw.  
26. ((automat* or "computer generated") adj3 
decision*).tw. 
 
27. or/1-26  
28. exp Decision Making/  
29. (decision adj3 (support or making)).tw.  
30. exp Decision Support Techniques/  
31. patient decision aid.tw.  
32. ((practice or decision) adj3 (chang* or alter)).tw.  
33. ((patient or consumer or customer) adj3 (choice* or 
decision* or decide or choos*)).tw. 
 
34. ((professional or clinic* or manage* or staff) adj3 
(choice* or decision* or decide or choos*)).tw. 
 
35. or/28-34  
36. meta-analysis/  
37. exp review literature/  
38. (meta-analy$ or meta analy$ or metaanaly$).tw.  
24 
 
39. meta analysis.pt.  
40. review academic.pt.  
41. review literature.pt.  
42. letter.pt.  
43. review of reported cases.pt.  
44. historical article.pt.  
45. review multicase.pt.  
46. 36 or 37 or 38 or 39 or 40 or 41  
47. 42 or 43 or 44 or 45  
48. 46 not 47  
49. animal/  
50. human/  
51. 49 and 50  
52. 49 not 51  
53. 48 not 52  
54. 27 and 35 and 53  
55. limit 54 to (english language and yr="2013 -Current")  
 
Medline  Artificial Intelligence 
RCTs 1. exp Artificial Intelligence/ 
 
2. (artificial intelligence or AI).tw.  
3. ((comput* or artificial or machine) adj3 
intelligence).tw. 
 
4. exp Machine Learning/  
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5. ((machine or artificial or deep) adj3 learning).tw.  
6. exp Algorithms/  
7. algorithm*.tw.  
8. (data driven or data-driven).tw.  
9. (computer adj3 (assist* or generat*)).tw.  
10. neural network*.tw.  
11. perceptron*.tw.  
12. connectionist model.tw.  
13. exp Support Vector Machine/  
14. (support vector adj3 (machine or network*)).tw.  
15. (statistic* adj3 (map* or learn*)).tw.  
16. chatbot*.tw.  
17. Virtual private agent*.tw.  
18. virtual intelligent agent*.tw.  
19. animated character*.tw.  
20. SIRI.tw.  
21. Recommendation system*.tw.  
22. ((image or face or facial) adj3 recogni*).tw.  
23. exp ROBOTICS/  
24. robot*.tw.  
25. (virtual adj3 assistant*).tw.  
26. ((automat* or "computer generated") adj3 
decision*).tw. 
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27. or/1-26  
28. exp Decision Making/  
29. (decision adj3 (support or making)).tw.  
30. exp Decision Support Techniques/  
31. patient decision aid.tw.  
32. ((practice or decision) adj3 (chang* or alter)).tw.  
33. ((patient or consumer or customer) adj3 (choice* or 
decision* or decide or choos*)).tw. 
 
34. ((professional or clinic* or manage* or staff) adj3 
(choice* or decision* or decide or choos*)).tw. 
 
35. or/28-34  
36. randomized controlled trial.pt.  
37. controlled clinical trial.pt.  
38. randomized controlled trials/  
39. random allocation/  
40. double-blind method/  
41. single-blind method/  
42. 36 or 37 or 38 or 39 or 40 or 41  
43. animal/  
44. human/  
45. 43 and 44  
46. 43 not 45  
47. 42 not 46  
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48. 27 and 35 and 47  
49. limit 48 to (english language and yr="2013 -Current")  
 
Embase  Artificial Intelligence 
Reviews1 1. exp artificial intelligence/ 
 
2. (artificial intelligence or AI).tw.  
3. ((comput* or artificial or machine) adj3 
intelligence).tw. 
 
4. exp machine learning/  
5. ((machine or artificial or deep) adj3 learning).tw.  
6. exp algorithm/  
7. algorithm*.tw.  
8. (data driven or data-driven).tw.  
9. (computer adj3 (assist* or generat*)).tw.  
10. neural network*.tw.  
11. perceptron*.tw.  
12. connectionist model.tw.  
13. exp support vector machine/  
14. (support vector adj3 (machine or network*)).tw.  
15. (statistic* adj3 (map* or learn*)).tw.  
16. chatbot*.tw.  
17. Virtual private agent*.tw.  
18. virtual intelligent agent*.tw.  
19. animated character*.tw.  
28 
 
20. SIRI.tw.  
21. Recommendation system*.tw.  
22. ((image or face or facial) adj3 recogni*).tw.  
23. exp robotics/  
24. robot*.tw.  
25. (virtual adj3 assistant*).tw.  
26. ((automat* or "computer generated") adj3 
decision*).tw. 
 
27. or/1-26  
28. exp decision making/  
29. (decision adj3 (support or making)).tw.  
30. exp decision support system/  
31. patient decision aid.tw.  
32. ((practice or decision) adj3 (chang* or alter)).tw.  
33. ((patient or consumer or customer) adj3 (choice* or 
decision* or decide or choos*)).tw. 
 
34. ((professional or clinic* or manage* or staff) adj3 
(choice* or decision* or decide or choos*)).tw. 
 
35. or/28-34  
36. exp Meta Analysis/  
37. ((meta adj analy$) or metaanalys$).tw.  
38. (systematic adj (review$1 or overview$1)).tw.  
39. or/36-38  
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40. cancerlit.ab.  
41. cochrane.ab.  
42. embase.ab.  
43. (psyclit or psychlit).ab.  
44. (psycinfo or psychinfo).ab.  
45. (cinahl or cinhal).ab.  
46. science citation index.ab.  
47. bids.ab.  
48. or/40-47  
49. reference lists.ab.  
50. bibliograph$.ab.  
51. hand-search$.ab.  
52. manual search$.ab.  
53. relevant journals.ab.  
54. or/49-53  
55. data extraction.ab.  
56. selection criteria.ab.  
57. 55 or 56  
58. review.pt.  
59. 57 and 58  
60. letter.pt.  
61. editorial.pt.  
62. animal/  
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63. human/  
64. 62 not (62 and 63)  
65. or/60-61,64  
66. 39 or 48 or 54 or 59  
67. 66 not 65  
68. 27 and 35 and 67  
69. limit 68 to (english language and yr="2013 -Current")  
 
Embase  Artificial Intelligence 
RCTs1 
 
1. exp artificial intelligence/  
2. (artificial intelligence or AI).tw.  
3. ((comput* or artificial or machine) adj3 
intelligence).tw. 
 
4. exp machine learning/  
5. ((machine or artificial or deep) adj3 learning).tw.  
6. exp algorithm/  
7. algorithm*.tw.  
8. (data driven or data-driven).tw.  
9. (computer adj3 (assist* or generat*)).tw.  
10. neural network*.tw.  
11. perceptron*.tw.  
12. connectionist model.tw.  
13. exp support vector machine/  
14. (support vector adj3 (machine or network*)).tw.  
31 
 
15. (statistic* adj3 (map* or learn*)).tw.  
16. chatbot*.tw.  
17. Virtual private agent*.tw.  
18. virtual intelligent agent*.tw.  
19. animated character*.tw.  
20. SIRI.tw.  
21. Recommendation system*.tw.  
22. ((image or face or facial) adj3 recogni*).tw.  
23. exp robotics/  
24. robot*.tw.  
25. (virtual adj3 assistant*).tw.  
26. ((automat* or "computer generated") adj3 
decision*).tw. 
 
27. or/1-26  
28. exp decision making/  
29. (decision adj3 (support or making)).tw.  
30. exp decision support system/  
31. patient decision aid.tw.  
32. ((practice or decision) adj3 (chang* or alter)).tw.  
33. ((patient or consumer or customer) adj3 (choice* or 
decision* or decide or choos*)).tw. 
 
34. ((professional or clinic* or manage* or staff) adj3 
(choice* or decision* or decide or choos*)).tw. 
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35. or/28-34  
36. Clinical Trial/  
37. Randomized Controlled Trial/  
38. controlled clinical trial/  
39. multicenter study/  
40. Phase 3 clinical trial/  
41. Phase 4 clinical trial/  
42. exp RANDOMIZATION/  
43. Single Blind Procedure/  
44. Double Blind Procedure/  
45. Crossover Procedure/  
46. PLACEBO/  
47. randomi?ed controlled trial$.tw.  
48. rct.tw.  
49. (random$ adj2 allocat$).tw.  
50. single blind$.tw.  
51. double blind$.tw.  
52. ((treble or triple) adj blind$).tw.  
53. placebo$.tw.  
54. Prospective Study/  
55. or/36-54  
56. Case Study/  
57. case report.tw.  
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58. abstract report/ or letter/  
59. Conference proceeding.pt.  
60. Conference abstract.pt.  
61. Editorial.pt.  
62. Letter.pt.  
63. Note.pt.  
64. or/56-63  
65. 55 not 64  
66. 27 and 35 and 65  
67. limit 66 to (english language and yr="2013 -Current")  
 
HMIC  Artificial Intelligence  
1. exp Artificial intelligence/  
2. (artificial intelligence or AI).tw.  
3. ((comput* or artificial or machine) adj3 
intelligence).tw. 
 
4. Machine Learning.tw.  
5. ((machine or artificial or deep) adj3 learning).tw.  
6. exp Algorithms/  
7. algorithm*.tw.  
8. (data driven or data-driven).tw.  
9. (computer adj3 (assist* or generat*)).tw.  
10. neural network*.tw.  
11. perceptron*.tw.  
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12. connectionist model.tw.  
13. (support vector adj3 (machine or network*)).tw.  
14. (statistic* adj3 (map* or learn*)).tw.  
15. chatbot*.tw.  
16. Virtual private agent*.tw.  
17. virtual intelligent agent*.tw.  
18. animated character*.tw.  
19. SIRI.tw.  
20. Recommendation system*.tw.  
21. ((image or face or facial) adj3 recogni*).tw.  
22. robot*.tw.  
23. (virtual adj3 assistant*).tw.  
24. ((automat* or "computer generated") adj3 
decision*).tw. 
 
25. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 
12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 
22 or 23 or 24 
 
26. exp Decision making/  
27. (decision adj3 (support or making)).tw.  
28. patient decision aid.tw.  
29. ((practice or decision) adj3 (chang* or alter)).tw.  
30. ((patient or consumer or customer) adj3 (choice* or 
decision* or decide or choos*)).tw. 
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31. ((professional or clinic* or manage* or staff) adj3 
(choice* or decision* or decide or choos*)).tw. 
 
32. 26 or 27 or 28 or 29 or 30 or 31  
33. 25 and 32  
34. limit 33 to yr="2013 -Current"  
 
 
CINAHL Artificial Intelligence Reviews  
 
Search 
Terms Search Options Actions 
S24 S14 AND S22  Limiters - Published Date: 20130101-20181031; English Language; 
Publication Type: Review 
Search modes - Boolean/Phrase 
S23 S14 AND S22  Search modes - Boolean/Phrase 
S22 S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21  Search modes - Boolean/Phrase 
S21 TX professional N2 decision OR TX management N2 decision OR TX clinic* 
N2 decision  
Search modes - Boolean/Phrase 
S20 TX practice N2 chang* OR TX decision N2 chang*  Search modes - Boolean/Phrase 
S19 TX patient decision aid  Search modes - Boolean/Phrase 
S18 (MM "Decision Making, Patient")  Search modes - Boolean/Phrase 
S17 (MM "Decision Support Systems, Clinical") OR (MM "Decision Support 
Systems, Management") OR (MM "Decision Support Techniques")  
Search modes - Boolean/Phrase 
S16 TX decision N2 support OR TX decision N2 mak*  Search modes - Boolean/Phrase 
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S15 (MM "Decision Making, Computer Assisted") OR (MM "Decision Making") 
OR (MM "Decision Making, Clinical")  
Search modes - Boolean/Phrase 
S14 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR 
S12 OR S13  
Search modes - Boolean/Phrase 
S13 TX Recommendation system*  Search modes - Boolean/Phrase 
S12 TX image N2 recognition OR TX fac* N2 recognition  Search modes - Boolean/Phrase 
S11 TX data driven  Search modes - Boolean/Phrase 
S10 TX support vector N2 machine  Search modes - Boolean/Phrase 
S9 TX Virtual private agent* OR TX virtual intelligent agent* OR TX virtual N2 
assistant*  
Search modes - Boolean/Phrase 
S8 TX SIRI OR TX chatbot OR TX animated character*  Search modes - Boolean/Phrase 
S7 TX connectionist model  Search modes - Boolean/Phrase 
S6 TX perceptron*  Search modes - Boolean/Phrase 
S5 TX neural network*  Search modes - Boolean/Phrase 
S4 TX computer N2 assist* OR TX computer N2 generat*  Search modes - Boolean/Phrase 
S3 TX Machine Learning OR TX computer intelligence OR TX algorithm*  Search modes - Boolean/Phrase 
S2 TX artificial intelligence  Search modes - Boolean/Phrase 
S1 (MM "Artificial Intelligence")  Search modes - Boolean/Phrase 
 
CINAHL Artificial Intelligence RCTs  
 
Search ID# Search Terms Search Options 
S24 S14 AND S22  Limiters - Published Date: 20130101-20181031; English Language; 
Randomized Controlled Trials 
37 
 
Search modes - Boolean/Phrase 
S23 S14 AND S22  Search modes - Boolean/Phrase 
S22 S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21  Search modes - Boolean/Phrase 
S21 TX professional N2 decision OR TX management N2 decision OR TX clinic* 
N2 decision  
Search modes - Boolean/Phrase 
S20 TX practice N2 chang* OR TX decision N2 chang*  Search modes - Boolean/Phrase 
S19 TX patient decision aid  Search modes - Boolean/Phrase 
S18 (MM "Decision Making, Patient")  Search modes - Boolean/Phrase 
S17 (MM "Decision Support Systems, Clinical") OR (MM "Decision Support 
Systems, Management") OR (MM "Decision Support Techniques")  
Search modes - Boolean/Phrase 
S16 TX decision N2 support OR TX decision N2 mak*  Search modes - Boolean/Phrase 
S15 (MM "Decision Making, Computer Assisted") OR (MM "Decision Making") 
OR (MM "Decision Making, Clinical")  
Search modes - Boolean/Phrase 
S14 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR 
S12 OR S13  
Search modes - Boolean/Phrase 
S13 TX Recommendation system*  Search modes - Boolean/Phrase 
S12 TX image N2 recognition OR TX fac* N2 recognition  Search modes - Boolean/Phrase 
S11 TX data driven  Search modes - Boolean/Phrase 
S10 TX support vector N2 machine  Search modes - Boolean/Phrase 
S9 TX Virtual private agent* OR TX virtual intelligent agent* OR TX virtual N2 
assistant*  
Search modes - Boolean/Phrase 
S8 TX SIRI OR TX chatbot OR TX animated character*  Search modes - Boolean/Phrase 
S7 TX connectionist model  Search modes - Boolean/Phrase 
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S6 TX perceptron*  Search modes - Boolean/Phrase 
S5 TX neural network*  Search modes - Boolean/Phrase 
S4 TX computer N2 assist* OR TX computer N2 generat*  Search modes - Boolean/Phrase 
S3 TX Machine Learning OR TX computer intelligence OR TX algorithm*  Search modes - Boolean/Phrase 
S2 TX artificial intelligence  Search modes - Boolean/Phrase 
S1 (MM "Artificial Intelligence")  Search modes - Boolean/Phrase 
Health Business Elite  
 
Search ID# Search Terms Search Options 
S24 S14 AND S21  Limiters - Publication Type: Periodical; Published Date: 20130101-
20181031 
Search modes - Boolean/Phrase 
S23 S14 AND S21  Limiters - Publication Type: Periodical; Published Date: 20130101-
20181031 
Search modes - Boolean/Phrase 
S22 S14 AND S21  Search modes - Boolean/Phrase 
S21 S15 OR S16 OR S17 OR S18 OR S19 OR S20  Search modes - Boolean/Phrase 
S20 TX professional N2 decision OR TX management N2 decision OR TX clinic* N2 
decision  
Search modes - Boolean/Phrase 
S19 TX practice N2 chang* OR TX decision N2 chang*  Search modes - Boolean/Phrase 
S18 TX patient decision aid  Search modes - Boolean/Phrase 
S17 SU Decision Support System  Search modes - Boolean/Phrase 
S16 TX decision N2 support OR TX decision N2 mak*  Search modes - Boolean/Phrase 
S15 SU Decision Making  Search modes - Boolean/Phrase 
39 
 
S14 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 
OR S13  
Search modes - Boolean/Phrase 
S13 TX Recommendation system*  Search modes - Boolean/Phrase 
S12 TX image N2 recognition OR TX fac* N2 recognition  Search modes - Boolean/Phrase 
S11 TX data driven  Search modes - Boolean/Phrase 
S10 TX support vector N2 machine  Search modes - Boolean/Phrase 
S9 TX Virtual private agent* OR TX virtual intelligent agent* OR TX virtual N2 
assistant*  
Search modes - Boolean/Phrase 
S8 TX SIRI OR TX chatbot OR TX animated character*  Search modes - Boolean/Phrase 
S7 TX connectionist model  Search modes - Boolean/Phrase 
S6 TX perceptron*  Search modes - Boolean/Phrase 
S5 TX neural network*  Search modes - Boolean/Phrase 
S4 TX computer N2 assist* OR TX computer N2 generat*  Search modes - Boolean/Phrase 
S3 TX Machine Learning OR TX computer intelligence OR TX algorithm*  Search modes - Boolean/Phrase 
S2 TX artificial intelligence  Search modes - Boolean/Phrase 
S1 SU artificial intelligence  Search modes - Boolean/Phrase 
 
PsychInfo Artificial Intelligence Reviews 
 
S14 
AND 
S21  
Limiters - Publication Year: 2013-2018; Language: English; Methodology: 
LITERATURE REVIEW; Exclude Dissertations 
Search modes - Boolean/Phrase 
View Results (119) 
View Details 
Edit 
S22 S14 AND S21  Search modes - Boolean/Phrase 
S21 S15 OR S16 OR S17 OR S18 OR S19 OR S20  Search modes - Boolean/Phrase 
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S20 TX professional N2 decision OR TX management N2 decision OR TX 
clinic* N2 decision  
Search modes - Boolean/Phrase 
S19 TX patient decision aid  Search modes - Boolean/Phrase 
S18 MJ decision aid  Search modes - Boolean/Phrase 
S17 MJ decision support  Search modes - Boolean/Phrase 
S16 TX decision N2 support OR TX decision N2 mak*  Search modes - Boolean/Phrase 
S15 MJ decision making  Search modes - Boolean/Phrase 
S14 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 
OR S12 OR S13  
Search modes - Boolean/Phrase 
S13 TX Recommendation system*  Search modes - Boolean/Phrase 
S12 TX image N2 recognition OR TX fac* N2 recognition  Search modes - Boolean/Phrase 
S11 TX data driven  Search modes - Boolean/Phrase 
S10 TX support vector N2 machine  Search modes - Boolean/Phrase 
S9 TX Virtual private agent* OR TX virtual intelligent agent* OR TX virtual 
N2 assistant*  
Search modes - Boolean/Phrase 
S8 TX SIRI OR TX chatbot OR TX animated character*  Search modes - Boolean/Phrase 
S7 TX connectionist model  Search modes - Boolean/Phrase 
S6 TX perceptron*  Search modes - Boolean/Phrase 
S5 TX neural network*  Search modes - Boolean/Phrase 
S4 TX computer N2 assist* OR TX computer N2 generat*  Search modes - Boolean/Phrase 
S3 TX Machine Learning OR TX computer intelligence OR TX algorithm*  Search modes - Boolean/Phrase 
S2 TX artificial intelligence  Search modes - Boolean/Phrase 
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S1 MJ Artificial Intelligence  Search modes - Boolean/Phrase 
 
Proquest Public Health and ASSIA 
(((((((artificial intelligence) OR ft(artificial intelligence) OR ft(Machine Learning) OR ft(computer intelligence) OR ft(algorithm) OR ft(neural network) OR 
ft(perceptron) OR ft(connectionist model) OR ft(SIRI) OR ft(chatbot)) AND at.exact("Literature Review" OR "Review")) AND la.exact("English")) AND 
at.exact("Literature Review" OR "Review")) AND la.exact("English")) AND at.exact("Literature Review" OR "Review")) AND la.exact("English") 
 
 
 
 
